WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on reports of the retirement of Richard Pazdur from the US FDA ...

WASHINGTON, DC (December 2, 2025) – The Biotechnology Innovation Organization (BIO), in partnership with the Council of State Bioscience Associations (CSBA), released today its latest biennial report ...

How the BIO IP Conference moved the conversation forward. Also, patient perspectives on diabetes innovation. (761 words, 3 minutes, 48 seconds) BIO IP Conference covers present and future of patent ...

Building on the success of the campaign to date, BIO is announcing a new series produced for us by BBC StoryWorks and launching in 2025. In this new iteration, the series will build on the ...

BIO seeks dynamic, professional candidates with industry expertise and knowledge for our open positions. If you're interested in joining our team, please see the links below to view our current ...

America leads the world in biotechnology innovation, yet the U.S. is the only country where half of every dollar spent on medicine goes to middlemen, hospital markups, and other hidden supply chain ...

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on the potential for 100% tariffs on branded or patented ...

One thing that we can all agree on is the need to give our children a fighting chance so they can lead long and productive lives. That is why it is critical to pass the bipartisan Give Kids a Chance ...

Intellectual property is at the center of U.S. biotech leadership. It plays an essential role in the development of lifesaving scientific advances - and the safeguarding of America's national security ...

As summer comes to a close, we look at two of BIO’s big priorities when Congress returns in September. We have the facts, plus more news to know before the holiday weekend. (735 words, 3 minutes, 40 ...

The Guide to Raising Institutional Private Capital is a comprehensive course designed to teach biotech CEOs and CFOs of companies that have already raised a Series A and are preparing for a Series B ...

From pandemic preparedness to food security, climate change to resource scarcity, the world requires innovative solutions to the challenges facing society. With its potential to create a diverse and ...